Skip to search formSkip to main contentSkip to account menu

CDKN2D gene

Known as: Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) Gene, p19, CDKN2D 
This gene is involved in the regulation of both cyclin-dependent kinase activity and cell cycle progression.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2017
2017
&NA; Medullary thyroid carcinoma (MTC), an aggressive form of thyroid cancer, occurs sporadically in approximately 75% of MTCs… 
2015
2015
AIM To investigate the underlying molecular mechanisms of miR-451 to inhibit proliferation of esophageal carcinoma cell line… 
2015
2015
This study aimed to investigate the p19 expression in cisplatin-treated rats and the role of p19 in the degeneration of inner ear… 
2013
2013
The regulation of granulosa cell proliferation is complex, and it is essential for normal follicular development in mammals. The… 
2013
2013
The expression of polypyrimidine tract-binding protein (PTB) is up-regulated in many types of cancer. Here, we studied the role… 
2013
2013
The identification of genetic markers associated with oral cancer is considered essential to improve the diagnosis, prognosis… 
2008
2008
High-risk types of HPV express the oncoproteins, E6 and E7, that can inactivate TP53 and RB1, respectively, and thus take control… 
2005
2005
DNA methylation in CpG islands is associated with transcriptional silencing. Accurate determination of cytosine methylation… 
1996
1996
Cyclin-dependent kinase inhibitors (CDKIs) can be classified into two groups based on the structure of the proteins. One group…